Sanofi prioritizes US for vaccines: Oxfam reaction
14 May 2020
"In lieu of global cooperation and solidarity, pharmaceutical companies are being empowered to act as kingmakers ―deciding who lives and who dies― and using this new-found power to extract subsidies and potentially high prices for new COVID-19 vaccines," said Oxfam today in response to reports that French pharmaceutical company, Sanofi, will prioritize the US for any new COVID-19 vaccine.